Latest & greatest articles for Anaphylaxis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on Anaphylaxis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on Anaphylaxis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for Anaphylaxis

2. Association Between Intravenous Thrombolysis and Anaphylaxis Among Medicare Beneficiaries With Acute Ischemic Stroke

Association Between Intravenous Thrombolysis and Anaphylaxis Among Medicare Beneficiaries With Acute Ischemic Stroke Background and Purpose- Allergic reactions, including anaphylaxis, can sometimes occur after intravenous thrombolysis in patients with acute ischemic stroke. However, it remains unclear whether patients with stroke who receive thrombolytic agents face a higher risk of anaphylaxis than those who do not receive thrombolytics. Methods- We performed a retrospective cohort study using (...) code 99.10). Our primary outcome was anaphylaxis, defined using an accepted International Classification of Diseases, Ninth Revision, Clinical Modification code algorithm (989.5, 995.0-4, 995.6x, E905, E905.3, E905.5, or E905.8-9). A secondary outcome was anaphylactic shock (995.0 or 995.6x). Multiple logistic regression was used to evaluate the association between intravenous thrombolysis and anaphylaxis after adjustment for demographics, vascular risk factors, the Charlson comorbidity index

2019 EvidenceUpdates

3. ASCIA Guidelines - Acute management of anaphylaxis

ASCIA Guidelines - Acute management of anaphylaxis 1 Acute Management of Anaphylaxis These guidelines are intended for medical practitioners and nurses providing first responder emergency care. The appendix includes additional information for emergency department staff, ambulance staff, rural or remote medical practitioners and nurses providing emergency care. Anaphylaxis definitions • Any acute onset illness with typical skin features (urticarial rash or erythema/flushing, and/or angioedema (...) ), PLUS involvement of respiratory and/or cardiovascular and/or persistent severe gastrointestinal symptoms; or • Any acute onset of hypotension or bronchospasm or upper airway obstruction where anaphylaxis is considered possible, even if typical skin features are not present. The most common triggers of anaphylaxis (severe allergic reaction) are foods, insect stings and drugs (medications). Signs and symptoms of allergic reactions Mild or moderate reactions • Swelling of lips, face, eyes • Hives

2019 Australasian Society of Clinical Immunology and Allergy

4. Perioperative Anaphylaxis Management Guidelines

Perioperative Anaphylaxis Management Guidelines Page 1 Guidelines Anaphylaxis 2016 Australian and New Zealand College of Anaesthetists (ANZCA) and Australian and New Zealand Anaesthetic Allergy Group (ANZAAG) Perioperative Anaphylaxis Management Guidelines INTRODUCTON Anaphylaxis is a life-threatening emergency that requires prompt recognition of signs and symptoms, early administration of adrenaline (epinephrine) in adequate dosage, and aggressive volume replacement. Due to the paucity (...) of randomised controlled trials of sufficient quality on the management of anaphylaxis 1-6 the recommendations in these guidelines are consensus statements developed by the Australian and New Zealand Anaesthetic Allergy Group (ANZAAG) and the Australian and New Zealand College of Anaesthetists (ANZCA) after a review of the literature 1-12 . Management of anaphylaxis consists of prompt diagnosis, immediate treatment, refractory management, and post crisis management. To facilitate the management of each

2019 Australian and New Zealand College of Anaesthetists

5. Anaphylaxis

Anaphylaxis Anaphylaxis - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Anaphylaxis Last reviewed: February 2019 Last updated: March 2019 Summary Sudden onset of respiratory or cardiovascular compromise, usually with a history of allergen exposure in sensitised individuals. Skin rash, wheezing and inspiratory stridor, hypotension, anxiety, nausea, and vomiting are the cardinal signs and symptoms. The diagnosis (...) is clinical. Allergy testing is helpful only for secondary prophylaxis. Securing the airway and initiating prompt treatment with epinephrine (adrenaline) may save lives. Comorbidities (e.g., coronary artery disease and COPD) may pose a treatment challenge and warrant expert consultation Definition Anaphylaxis is an acute, severe, life-threatening allergic reaction in pre-sensitised individuals, leading to a systemic response caused by the release of immune and inflammatory mediators from basophils

2019 BMJ Best Practice

6. Preventing, diagnosing and managing anaphylaxis

Preventing, diagnosing and managing anaphylaxis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2019 PROSPERO

7. Angio-oedema and anaphylaxis

Angio-oedema and anaphylaxis Angio-oedema and anaphylaxis - NICE CKS Share Angio-oedema and anaphylaxis: Summary Angio-oedema is swelling of deep dermis, subcutaneous, or submucosal tissue, often affecting the face (lips, tongue, and eyelids), genitalia, hands, or feet. Less commonly, submucosal swelling affects the bowel and airway. The main types are allergic angio-oedema, non-allergic drug reaction (usually caused by angiotensin-converting enzyme [ACE] inhibitor treatment), hereditary angio (...) -oedema (an inherited genetic abnormality), acquired angio-oedema (usually secondary to lymphoma or a connective tissue disorder), and idiopathic angio-oedema. Anaphylaxis is a severe, life-threatening, generalized or systemic hypersensitivity reaction characterized by rapidly developing airway and/or breathing and/or circulation problems usually associated with skin and mucosal changes. The mechanism for angio-oedema and anaphylaxis is the same, as both histamine and/or bradykinin are involved

2018 NICE Clinical Knowledge Summaries

8. Anaphylaxis

Anaphylaxis Printed copies of this document may not be up to date, obtain the most recent version from www.cats.nhs.uk Children’s Acute Transport Service CATS Clinical Guideline Anaphylaxis/Latex Allergy Document Control Information Author D Lutman Author Position Consultant Document Owner E Polke Document Owner Position Service Coordinator Document Version Version 4 Replaces Version Version 3 First Introduced Review Schedule 2 Yearly Active Date January 2016 Next Review January 2020 CATS (...) anaphylaxis and suggest precautions to prevent allergic reactions in a patient suspected of latex allergy. 1. Assessment 1.1 Anaphylaxis is likely when all of the following 3 criteria are met: • Sudden onset and rapid progression of symptoms • Life-threatening Airway and/or Breathing and/or Circulation problems • Skin and/or mucosal changes (flushing, urticarial, angioedema) 1.2 A history of exposure to an allergen supports the diagnosis but is not essential. 1.3 Anaphylaxis should be suspected when

2018 Children's Acute Transport Service

9. Systematic review and meta-analysis of epinephrine, corticosteroids, and antihistamines versus no therapy for anaphylaxis

Systematic review and meta-analysis of epinephrine, corticosteroids, and antihistamines versus no therapy for anaphylaxis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

10. IgG-Mediated Anaphylaxis: Biomarker Identification via Meta-analysis.

IgG-Mediated Anaphylaxis: Biomarker Identification via Meta-analysis. Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures

2018 PROSPERO

11. Allergen exposure thresholds for life-threatening anaphylaxis to food allergens

Allergen exposure thresholds for life-threatening anaphylaxis to food allergens Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2018 PROSPERO

12. Systematic review and meta analysis of the overall prognosis of patients presenting with anaphylaxis out of the hospital

Systematic review and meta analysis of the overall prognosis of patients presenting with anaphylaxis out of the hospital Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

13. The application of sulfite containing local anaesthetics and its relationship to true anaphylaxis reaction: a systematic review

The application of sulfite containing local anaesthetics and its relationship to true anaphylaxis reaction: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

14. Comorbidites involved in the severity of anaphylaxis: a systematic review and meta-analysis of observational studies

Comorbidites involved in the severity of anaphylaxis: a systematic review and meta-analysis of observational studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2018 PROSPERO

15. Anaphylaxis

Anaphylaxis Anaphylaxis - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Anaphylaxis Last reviewed: February 2019 Last updated: March 2019 Summary Sudden onset of respiratory or cardiovascular compromise, usually with a history of allergen exposure in sensitised individuals. Skin rash, wheezing and inspiratory stridor, hypotension, anxiety, nausea, and vomiting are the cardinal signs and symptoms. The diagnosis (...) is clinical. Allergy testing is helpful only for secondary prophylaxis. Securing the airway and initiating prompt treatment with epinephrine (adrenaline) may save lives. Comorbidities (e.g., coronary artery disease and COPD) may pose a treatment challenge and warrant expert consultation Definition Anaphylaxis is an acute, severe, life-threatening allergic reaction in pre-sensitised individuals, leading to a systemic response caused by the release of immune and inflammatory mediators from basophils

2018 BMJ Best Practice

16. In-practice management of anaphylaxis: a systematic review of prehospital and hospital care

In-practice management of anaphylaxis: a systematic review of prehospital and hospital care Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2018 PROSPERO

17. CRACKCast E119 – Allergy, Hypersensitivity, Angioedema, and Anaphylaxis

CRACKCast E119 – Allergy, Hypersensitivity, Angioedema, and Anaphylaxis CRACKCast E119 – Allergy, Hypersensitivity, Angioedema, and Anaphylaxis - CanadiEM CRACKCast E119 – Allergy, Hypersensitivity, Angioedema, and Anaphylaxis In , by Chris Lipp October 19, 2017 This episode of CRACKCast covers Rosen’s Chapter 119 (109 in 9th), Allergy, Hypersensitivity, Angioedema, and Anaphylaxis. Patients suffering from acute allergic reactions, anaphylaxis, and angioedema are amongst the most unstable (...) , raised, and pruritic rash . Angioedema Another important syndrome, mediated by either an allergic (histaminergic) mechanism in response to exposure to foods, drugs, physical stimuli, or a non-allergic (non-histaminergic) mechanism (e.g., hereditary angioedema [HAE], or angiotensin-converting enzyme [ACE] inhibitor). Angioedema is characterized by edema of the subcutaneous or submucosal tissues, which can cause airway compromise if the tongue or larynx is involved. Anaphylaxis A life-threatening

2017 CandiEM

18. Drug‐induced anaphylaxis in the emergency room (Full text)

Drug‐induced anaphylaxis in the emergency room Anaphylaxis is a life-threatening, systemic allergic reaction that presents unique challenges for emergency care practitioners. Anaphylaxis occurs more frequently than previously believed. Therefore, proper knowledge regarding the epidemiology, mechanisms, symptoms, diagnosis, and treatment of anaphylaxis is essential. In particular, the initial treatment strategy, followed by correct diagnosis, in the emergency room is critical for preventing (...) fatal anaphylaxis, although making a diagnosis is not easy because of the broad and often atypical presentation of anaphylaxis. To this end, the clinical criteria proposed by the National Institute of Allergy and Infectious Diseases and the Food Allergy and Anaphylaxis Network are useful, which, together with a differential diagnosis, could enable a more accurate diagnosis. Additional in vitro tests, such as plasma histamine and tryptase measurements, are also helpful. It should be emphasized

2017 Acute medicine & surgery

19. ASCIA Checklist - Travel for people with allergy, asthma and anaphylaxis

ASCIA Checklist - Travel for people with allergy, asthma and anaphylaxis ASCIA Travel Plan: Anaphylaxis - Australasian Society of Clinical Immunology and Allergy (ASCIA) | | ASCIA Travel Plan: Anaphylaxis Other travel information for people at risk of anaphylaxis is available from Allergy & Anaphylaxis Australia: Page updated January 2019 Site last updated: 6 Nov 2019 Member Login Remember Me Log in ASCIA Update Information for the community about allergic diseases, immunodeficiencies and other

2017 Australasian Society of Clinical Immunology and Allergy

20. Systematic review and meta-analysis of the need for more than 1 dose of adrenaline (epinephrine) given during anaphylaxis

Systematic review and meta-analysis of the need for more than 1 dose of adrenaline (epinephrine) given during anaphylaxis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2017 PROSPERO